Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2007 Summer Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2007 Summer Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    In vivo and in vitro analysis of In-111 and Cu-64 labeled PNA-peptides in mice [abstract]

    Bodkin, Nicole C.
    Jia, Fang
    Lewis, Michael R.
    View/Open
    [PDF] In vivo and in vitro analysis of In-111 and Cu-64.pdf (19.76Kb)
    Date
    2007
    Contributor
    University of Missouri-Columbia. Office of Undergraduate Research
    Format
    Presentation
    Metadata
    [+] Show full item record
    Abstract
    The B-cell lymphoma/leukemia-2 (bcl-2) gene is overexpressed in non-Hodgkin's lymphoma. It produces a protein that blocks apoptosis and is strongly correlated with increased relapse rates after chemotherapy and poor overall survival. In this study, radiolabeled peptide nucleic acid (PNA) probes were delivered to bcl-2 mRNA-deficient and -rich tumor models in mice to determine whether the probes are specific for cells that express bcl-2 mRNA and to differentiate between positive and negative bcl-2 tumors. A peptide, Tyr3-octreotate, was attached to the PNA to target somatostatin receptors on the surface of tumor cells, where the PNA can then be delivered into the cell and bind to bcl-2 mRNA. In vitro efflux studies of 111In-DOTA-anti-bcl-2-PNA-Tyr3-octreotate were performed in somatostatin receptor positive Mec-1 (bcl-2 positive) and Ramos (bcl-2 negative) cells. The cell associated radioactivity was 14.9% in Ramos cells, as compared with 60% in Mec-1 cells at 4 h post-injection, signifying that PNA is washed out of the Ramos cells while there is higher retention in Mec-1 cells. In in vivo studies, 111In-DOTA-anti-bcl-2-PNA-Tyr3-ocreotate and a modified compound, 64Cu-DOTA-anti-bcl-2-PNA-T(s)-Tyr3-octreotate, were injected into Ramos-bearing nude mice and Mec-1-bearing SCID mice, and organ uptakes were compared at 48 h post-injection. The results showed a 0.18% injected dose per gram of tissue (ID/g) tumor uptake with the 111In labeled compound in Ramos mice and 1.33% ID/g in Mec-1 mice. The 64Cu labeled compound in the Ramos mice showed a 0.69% ID/g tumor uptake and 1.12% ID/g in Mec-1 mice. Both studies showed a significantly lower tumor uptake in Ramos mice than in Mec-1 mice, concluding that the PNA in both compounds are specific for bcl-2 mRNA.
    URI
    http://hdl.handle.net/10355/988
    Collections
    • 2007 Summer Undergraduate Research and Creative Achievements Forum (MU)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems